Patent · US Active

Composition for treating burn wounds

US11737998B2 · kind B2 · utility

0Cited by
1References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 22, 2021
Grant dateAug 29, 2023
Priority date
Expiry dateApr 2, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P17/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition for treating a burn wound, containing a variety of ingredients, including a fatty acid 261-639 mg, an organic substance 3.5-350 mg, a carbohydrate 0.02-60 mg, a vitamin 9-13 μg, a microelement 3.04-5.5 mg, an antibiotic 0.6-70 mg, and an amino acid 105-335 mg. The significant therapeutic effects include effectively promoting repair of a burn wound, anti-infection, inhibiting scar hyperplasia, no toxic side effect, convenient use, fast absorption, economical efficiency, etc. The composition provides patients with an efficient, economical, convenient and practical treatment for burn wounds, which greatly reduces the burden on patients, and effectively compensates for the various deficiencies of the current treatments for the non-healing burn wounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.